Not unique to Pab. Nobody in Oz biotech are landing blockbuster deals (bodacious upfronts, bombastic milestones and heroic royalty rates) either. What's wrong with oz biotech may be the right question.
Having said that, not many have tie ups (albeit lazy n loose) with Amgen.
good for pab/sm6, page-5
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $6.723K | 1.120M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 9665158 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 597624 | 2 |
View Market Depth
| Last trade - 14.44pm 23/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |